| Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium DYC Heng, JC Wells, BI Rini, B Beuselinck, JL Lee, JJ Knox, ... European urology 66 (4), 704-710, 2014 | 520 | 2014 |
| Disulfiram when combined with copper enhances the therapeutic effects of temozolomide for the treatment of glioblastoma X Lun, JC Wells, N Grinshtein, JC King, X Hao, NH Dang, X Wang, ... Clinical Cancer Research 22 (15), 3860-3875, 2016 | 193 | 2016 |
| Evaluation of clear cell, papillary, and chromophobe renal cell carcinoma metastasis sites and association with survival S Dudani, G De Velasco, JC Wells, CL Gan, F Donskov, C Porta, ... JAMA network open 4 (1), e2021869-e2021869, 2021 | 177 | 2021 |
| Change in neutrophil-to-lymphocyte ratio in response to targeted therapy for metastatic renal cell carcinoma as a prognosticator and biomarker of efficacy AJ Templeton, JJ Knox, X Lin, R Simantov, W Xie, N Lawrence, R Broom, ... European urology 70 (2), 358-364, 2016 | 172 | 2016 |
| An analysis of contemporary oncology randomized clinical trials from low/middle-income vs high-income countries JC Wells, S Sharma, JC Del Paggio, WM Hopman, B Gyawali, D Mukherji, ... JAMA oncology 7 (3), 379-385, 2021 | 124 | 2021 |
| The clinical activity of PD-1/PD-L1 inhibitors in metastatic non–clear cell renal cell carcinoma RR McKay, D Bossé, W Xie, SAM Wankowicz, A Flaifel, R Brandao, ... Cancer immunology research 6 (7), 758-765, 2018 | 120 | 2018 |
| First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium JM Ruiz-Morales, M Swierkowski, JC Wells, AP Fraccon, F Pasini, ... European Journal of Cancer 65, 102-108, 2016 | 93 | 2016 |
| Third-line targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium JC Wells, I Stukalin, C Norton, S Srinivas, JL Lee, F Donskov, ... European urology 71 (2), 204-209, 2017 | 89 | 2017 |
| First-line immuno-oncology combination therapies in metastatic renal-cell carcinoma: results from the international metastatic renal-cell carcinoma database consortium S Dudani, J Graham, JC Wells, Z Bakouny, SK Pal, N Dizman, F Donskov, ... European urology 76 (6), 861-867, 2019 | 80 | 2019 |
| Upfront cytoreductive nephrectomy for metastatic renal cell carcinoma treated with immune checkpoint inhibitors or targeted therapy: an observational study from the … Z Bakouny, T El Zarif, S Dudani, JC Wells, CL Gan, F Donskov, J Shapiro, ... European urology 83 (2), 145-151, 2023 | 77 | 2023 |
| Checkpoint inhibitors in patients with metastatic renal cell carcinoma: results from the international metastatic renal cell carcinoma database consortium SM Yip, C Wells, R Moreira, A Wong, S Srinivas, B Beuselinck, C Porta, ... Cancer 124 (18), 3677-3683, 2018 | 71 | 2018 |
| Risk factors and model for predicting toxicity‐related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth … MD Kaymakcalan, W Xie, L Albiges, SA North, CK Kollmannsberger, ... Cancer 122 (3), 411-419, 2016 | 69 | 2016 |
| Deferred cytoreductive nephrectomy in patients with newly diagnosed metastatic renal cell carcinoma B Bhindi, J Graham, JC Wells, Z Bakouny, F Donskov, A Fraccon, F Pasini, ... European urology 78 (4), 615-623, 2020 | 67 | 2020 |
| A retrospective, Canadian multi‐center study examining the impact of prior response to abiraterone acetate on efficacy of docetaxel in metastatic castration‐resistant prostate … AA Azad, R Leibowitz‐Amit, BJ Eigl, R Lester, JC Wells, RN Murray, ... The Prostate 74 (15), 1544-1550, 2014 | 62 | 2014 |
| Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies N Kroeger, AJ Pantuck, JC Wells, N Lawrence, R Broom, JJ Kim, ... European urology 68 (3), 506-515, 2015 | 49 | 2015 |
| Characterizing the outcomes of metastatic papillary renal cell carcinoma J Connor Wells, F Donskov, AP Fraccon, F Pasini, GA Bjarnason, ... Cancer medicine 6 (5), 902-909, 2017 | 47 | 2017 |
| Synchronous versus metachronous metastatic disease: impact of time to metastasis on patient outcome—results from the International Metastatic Renal Cell Carcinoma Database … F Donskov, W Xie, A Overby, JC Wells, AP Fraccon, CS Sacco, C Porta, ... European urology oncology 3 (4), 530-539, 2020 | 41 | 2020 |
| Outcomes for international metastatic renal cell carcinoma database consortium prognostic groups in contemporary first-line combination therapies for metastatic renal cell … MS Ernst, V Navani, JC Wells, F Donskov, N Basappa, C Labaki, SK Pal, ... European Urology 84 (1), 109-116, 2023 | 39 | 2023 |
| Cytoreductive nephrectomy in metastatic papillary renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium J Graham, JC Wells, F Donskov, JL Lee, A Fraccon, F Pasini, C Porta, ... European urology oncology 2 (6), 643-648, 2019 | 38 | 2019 |
| Outcomes of patients with metastatic renal cell carcinoma treated with targeted therapy after immuno-oncology checkpoint inhibitors J Graham, AY Shah, JC Wells, RR McKay, U Vaishampayan, A Hansen, ... European Urology Oncology 4 (1), 102-111, 2021 | 37 | 2021 |
